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Abstract 
2-Styrylchromones, although scarce in nature, constitute a group of oxygen heterocyclic 
compounds which have shown significant biological activities. Their transformation and the 
transformation of their 3-isoanalogues into other biologically active compounds have been 
exploited. This short review describes the most recent work on the synthesis, biological 
evaluation and transformation of 2- and 3-styrylchromones. 
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Introduction 
 
Chromones and their derivatives of different oxidation level are well known naturally occurring 
oxygen-containing heterocyclic compounds which perform important biological functions in 
Nature. It is known that certain natural and synthetic derivatives possess important biological 
activities, such as anti-tumor, anti-hepatotoxic, antioxidant, anti-inflammatory, anti-spasmolytic, 
oestrogenic and antibacterial activities.1-5 These applications have stimulated a continuous search 
for the synthesis of new compounds in this field and led already to the appearance of some drugs 
on the market.6 
2-Styrylchromones are one of the scarcest classes of natural chromones. Hormothamnione 1 
and 6-desmethoxyhormothamnione 2 are the first and to the best of our knowledge the only 
naturally occurring styrylchromones isolated from the marine crytophyte Chrysophaeum taylori 
(Figure 1).7,8 Hormathamnione 1 is exceptionally cytotoxic to P388 lymphocytic leukemia and 
HL-60 promyelocytic leukemia cell lines in vitro and appears to be a selective inhibitor of RNA 
synthesis.7 6-Desmethoxyhormothamnione 2 showed cytotoxicity to 9 KB cell lines.8 These 
pharmacological activities and potential medicinal uses in addition to the fact that the isolation 
and purification of these 2-styrylchromones 1 and 2 are difficult, in view of very low 
concentration in the rare algae, have stimulated even more extensive studies related to their 
synthesis.9 
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Although 2-styrylchromones constitute a small family of naturally occurring compounds, 
their synthesis has been extensively studied. A previous review10 summarized the literature on 
the chemistry of 2-strylchromones and their 3-isoanalogues with emphasis on successful 
synthetic strategies and reactivity in Diels-Alder and photo-oxidative reactions. This review 
aims, therefore, to cover the work on the synthesis, biological evaluation and transformation of 
both 2- and 3-styrylchromones since 1993. 
 
1. Preparation of styrylchromones 
 
1.1.Synthesis of 3-styrylchromones 
Despite the structural analogy of the 3-styrylchromones with isoflavones and their relationship 
with the well-studied 2-styrylchromones there has been limited interest in their study. The first 
example regarding the formation of only one derivative of these chromones was published in 
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198711 and since then there were no significant developments. It was necessary to wait ten years 
for another publication on the establishment of a new synthesis of several new derivatives.12 This 
synthetic route is analogous to the oxidative rearrangement of 2’-hydroxychalcones to 
isoflavones.13 In fact the treatment of (E,E)-2’-hydroxycinnamylideneacetophenones 3 with 
thallium(III) trinitrate involves a cinnamyl group transposition from C-β to C-α, resulting in the 
formation of intermediates 3-alkyl-4-aryl-1-(2-hydroxyphenyl)-2-dimethoxymethyl-3-buten-1-
ones 4. Treatment of acetals 4 with diluted hydrochloric acid gave the corresponding 3-styryl-
chromones 5 (Scheme 1). This method gave rise stereoselectively to the (E)-isomers and is the 
only known strategy which does not use a chromone as starting material, but has some 
limitations, it uses very toxic reagents, such as thallium(III) trinitrate, and only 3-(α-
alkylstyryl)chromones could be obtained.12 
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Scheme 1 
 
The use of 3-formylchromones in the synthesis of heterocyclic systems has attracted the 
attention of many researchers, since their convenient synthesis was reported in the 1970’s.14 
Very recently, the reactivity of the electrophilic 3-formyl group was successfully exploited in the 
synthesis of 3-styrylchromones, as well.15-18 The first publication on this issue appeared in 
200215 and consists of the condensation of 3-formylchromones 6 with 2,4-dinitrotoluene 7 in 
pyridine (Scheme 2). New and simple 3-styrylchromones 8 have been obtained with this 
synthetic approach. A modification on this method16,17 which consists of the condensation of 3-
formyl-chromones 6 with phenylacetic acids 9 followed by decarboxylation reaction, allowed the 
synthesis of new 3-styrylchromone derivatives 10 and gave only the (E) isomer.17 
 
Issue in Honor of Prof. Sándor Antus ARKIVOC 2004 (vii) 106-123 
ISSN 1424-6376 Page 109 ©ARKAT USA, Inc 
O
O
CHO
CO2H
R'
NO2
NO2
6
7
R
+ py
reflux
O
O
NO28
NO2
R
+
9
py
reflux O
O
R'10
R
R = H, CH3, Cl
R' = H, NO2, CF3
H3C
 
 
Scheme 2 
 
The third synthetic method for 3-styrylchromones involves the Wittig reaction of 3-formyl-
chromones 6 with benzylic ylides 11 (Scheme 3).18 This new approach seems to be of general 
use and gave a diastereomeric mixture of (E) and (Z)-3-styrylchromones 12 and 13, the (Z)-
isomer being the most abundant one. The obtained diastereomers have been separated by thin-
layer chromatography. 
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In 1999 Samat and coworkers reported the synthesis of novel 3-styrylchromones 17 which 
can also be regarded as 3-styrylflavones.19 These compounds have been obtained from the 
reaction of 1-(2-hydroxyphenyl)-3-phenylpropan-1,3-diones 14 and phenylacetaldehydes 15 
under a mild acid-catalyzed condition (acetic acid), (Scheme 4). The proposed possible 
mechanism involves an acid-catalyzed aldol reaction of 14 with aldehydes 15, leading to diketo-
compounds 16 which after [1,5]-benzylic proton migration cyclize into the obtained 3-styryl-
chromones 17. The structure of these novel 3-styrylchromones 17 was established by X-Ray 
analysis.19 
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1.1 Synthesis of 2-styrylchromones 
In the previous paragraphs new synthetic approaches used in the synthesis of  
3-styrylchromones were described. In the case of their 2-isoanalogues, which were prior 
extensively studied; there were since 199310 some publications with innovating strategies. The 
reports found in literature deal with improvements of the most promising approaches, such as: 1) 
aldol condensation / oxidative cyclization20-26 and 2) Baker-Venkataraman rearrangement.26-31 
Taking into consideration the important biological activities described for 2-styryl-
chromones (vide infra), it is advantageous if these compounds could be available by simple and 
efficient synthetic transformations. For that reason almost all reports on the synthesis of new 2-
styrylchromones include their transformation and/or biological activities evaluations. 
 
1.1.1 Aldol condensation / oxidative cyclization 
This two-step approach involves an aldol reaction followed by an oxidative cyclization. The 
base-catalyzed aldol reaction of cinnamaldehydes 19 with 2′-hydroxy-acetophenones 18 in 
methanolic solutions affords (E,E)-2′-hydroxycinnamylidene-acetophenones 20 (Scheme 5). 
Much more attention was paid to the oxidative cyclisation of 20 into (E)-2-styrylchromones 21 
and several oxidative reagent systems were proposed.10,21-26 The most successful one uses 
DMSO and a catalytic amount of iodine (Scheme 5).25 We proved that bromine can also be 
successfully used for this oxidative step and that the amount of the halogen used (I2 or Br2) and 
the refluxing time are very important parameters in the reaction results. Treatment of 2′-
hydroxycinnamylideneacetophenones 20 with one molar equivalent of halogen, in refluxing 
DMSO for 30 min., allowed both the oxidative cyclization into 2-styrylchromones and the 
halogenation of their most activated positions. This method constitutes a new synthetic route for 
halogenated 2-styrylchromones 22.22,24 When 2′-benzyloxy-6′-hydroxycinnamylidene-
acetophenones 20 (R = OBn) were reacted in the presence of a catalytic amount of halogen the 
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reaction of longer period (2 hours) resulted in not only the expected oxidative cyclizations but a 
debenzylation leading to 5-hydroxy-2-styrylchromones 21 (R3 = OH).20,24  
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1.1.2 Baker-Venkataraman rearrangement 
The most common procedures in the Baker-Venkataraman rearrangement (Scheme 6) consist of 
the O-acylation of a 2′-hydroxyacetophenone 23 followed by a base-catalyzed rearrangement of 
the formed ester 25 into 5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-ones 26 (structures 
involved in the keto-enol equilibrium). The last step of the synthesis is the cyclodehydration of 
these diketones into the desired 2-styrylchromones 27.10 The main reported modifications on this 
method consists of changes in the reagent systems used and/or in the elimination of one 
procedure step. 
One of the first publications since 1993 on the synthesis of 2-styrylchromones, using this 
procedure, reports a two-step modification.28 The authors indicated that refluxing 2′-hydroxy- 
3′-allylacetophenones 23 (R = 3′-allyl) with cinnamoyl chlorides 24 (X =Cl) in potassium 
carbonate/acetone medium yields directly 1-(3-allyl-2-hydroxyaryl)-5-aryl-3-hydroxy- 
2,4-pentadien-1-ones 26 which were then cyclized in acid medium into 2-styrylchromones 27 
(Scheme 6, steps A and B.i). More recently, the same research group has synthesized some  
2-(2′-vinylthiophene)chromones 30 (2-styrylchromone-type compounds) in one step, by 
condensation of appropriate 2′,4′-dihydroxyacetophenones 28 and thiophene-2-acroyl chloride 
29 (Scheme 7).32 
Another important modification of the Baker-Venkataraman method was the improvement in 
the cyclodehydration step, which was originally performed in strong acidic conditions. However, 
it was also reported that several 2-styrylchromones 27 could be obtained by a three-step 
procedure where the cyclodehydration of 5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-
ones 26 was achieved with p-toluenesulfonic acid or with a catalytic amount of iodine in hot 
DMSO (90-100oC) (Scheme 6, step B.ii).29,31  
The O-acylation is generally an easy step, but in some cases the use of classical procedures to 
the synthesis of 5-hydroxy-2-styrylchromones 27 (R = 5-OH), the nucleus which is present in the 
natural derivatives, the O-acylation was found to be difficult. Recent work30 reports that this step 
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can be successfully achieved. Treatment of the appropriate 2′,6′-dihydroxyacetophenone 23 (R = 
6′-OH) with cinnamic acids 24 (X = OH) in the presence of N,N-dicyclohexyl-carbodiimide 
(DCC) and a catalytic amount of 4-pyrrolidinopyridine (Scheme 6, step C). 
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2. Biological evaluation of 2- and 3-styrylchromones 
 
The significant anti-allergic activity of 2-styrylchromones has been recognized more than twenty 
years ago33 and since then their synthesis and biological evaluations of these compounds have 
been the subject of several studies, which were also stimulated by the discovery of the natural 
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derivatives and of their biological activity.7,8 This paper does not intend to describe exhaustively 
biological properties, only the most recent and significant reports on the effects of 
styrylchromones are listed here. 
Human rhinoviruses (HRVs) are the most frequent cause of the common cold and therefore 
responsible for several chronic conditions, such as asthma and sinusitis. Consequently HRV has 
become a target for antiviral research. Desideri and coworkers focused their interest on study of 
the anti-rhinovirus activity of 2-styrylchromones.34 They selected two serotypes of human 
rhinovirus, 1B and 14, and tested several 2-styrylchromones (32, Figure 2). From their study one 
can conclude that styrylchromones can be considered as promising new antiviral compounds. 
It has also been proved that 3′-allyl-4′,5,7-trimethoxy-2-styrylchromone (33, Figure 2) can 
inhibit the phosphorylative system and the electron transfer via the respiratory chain of rat liver 
mitochondria.30 This interaction indicates that 3′-allyl-4′,5,7-trimethoxy-2-styrylchromone can 
show potential anticancer activity. 
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Quercetin (3,5,7,3′,4′-pentahydroxyflavone) (34, Figure 3) is a natural compound with a 
widespread occurrence and appears to help the fight against a host of disorders, from asthma to 
cancer and heart diseases. As an antioxidant, it combats the destructive "free radical" species that 
play an “important role” in many human diseases. Quercetin is just the most famous example, 
since several flavonoids have the capacity to act as antioxidants.36,37 Taking into account these 
important properties and the similarity of 2-styrylchromones with flavones, several 
polyhydroxylated 2-styrylchromones 35, 36 have been studied to demonstrate their potential 
biological applications experimentally.38-40 In one of these studies certain hydroxylated -2-
styrylchromones 36 have been demonstrated to act as potent xanthine oxidase inhibitors.38 The 
study indicated that more attention should be devoted to these 2-styrylchromones to evaluate 
their potential use as agents in the treatment of diseases related to xanthine oxidase activity (e.g. 
gout, hypertension and hepatitis). Recently, the same polyhydroxylated 2-styrylchromones 35, 36 
were found to be potent hepatoprotectors against tert-butyl-hydroperoxide39 and their inhibitory 
effect on the Cu2+-induced oxidation of isolated human serum low-density lipoproteins, a well-
established in vitro model of lipid peroxidation, was also studied in order to explore their 
antioxidant properties.40 
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Biological activities of 3-styrylchromones have hardly been studied; to our knowledge only 
one paper reported biological evaluations of this type of compounds.15 Some 2′,4′-dinitro-3-
styrylchromones 8 (Figure 4) were screened for their antibacterial activities against E. coli and S. 
albus and their fungicidal activities against A. niger and A. teniussiama. All compounds showed 
moderate bactericidal activities and moderate to excellent fungicidal activities. 
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3. Reactivity of 2- and 3-styrylchromones  
 
It has been known since 1954 that 2-styrylchromones can participate in pericyclic reactions as 
dienes whilst photo-oxidative cyclizations into 12H-benzo[a]xanthen-12-one was demonstrated 
more than twenty years later.10 Since 1993 different types of reactivity have been studied, such 
as their use as dienophiles and dipolarophiles in cycloaddition reactions to synthesize new 
potential biological active heterocyclic compounds. 
Although the photo-oxidative cyclization of 2-styrylchromones 37 is not a new reaction in 
1993 we reported a new, less dangerous and more efficient methodology (Scheme 8).23,25,41 The 
major improvements were: i) the use of chloroform as solvent instead of benzene; ii) the use of 
daylight instead of UV light; iii) the use of borosilicate glass vessels instead of quartz vessels, 
and, as a result the expected xanthones 38 were obtained in better yields. 
37
O
O
R
R'
O
O
R
R'
O
O
R
R'
38
R = H, Me, Et
R' = H, Cl
hν
 
Scheme 8 
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3.1.Styrylchromones as dienes 
The transformation of 2-styrylchromones into other heterocyclic compounds by pericyclic 
reactions started with their use as dienes in Diels-Alder reactions.10 More recently, a novel 
approach to the synthesis of xanthones 42 was reported utilizing the [4+2] cycloaddition 
reactions of 2-styrylchromones 39 with pyrrolidine enamine 40, formed in situ from pyrrolidine 
and acetone (Scheme 9).42 The proposed mechanism involves the tetrahydroxanthones 41 as the 
initial products of pyrrolidine elimination from the Diels-Alder adducts. Adducts 41 are the 
precursors of the fully aromatized compounds 42, via migration of the exocyclic double bond 
and a subsequent dehydrogenation of the C-ring. This mechanism was confirmed by replacing 
acetone with 2-butanone in the generation of the enamine dienophile 43. In this case the 
tetrahydroxanthones 44 were the major reaction products and there was neither rearrangement 
and aromatization, however 1-methylidene-2-methyltetrahydroxanthones 44 were easily 
converted into the desired 1,2-dimethylxanthone 45 by treatment with strong acid (Scheme 9). 
The transformation of 3-styrylchromones into other heterocyclic compounds is scarce; as far 
as we are aware there is only one publication on their reactivity as dienes. The Diels-Alder 
reactions of 3-styryl-chromones were investigated using very reactive dienophiles, such as N-
methyl and N-phenyl-maleimide, under microwave irradiation.43 Using N-methylmaleimide, (Z)-
3-styrylchromones 13 gave the expected endo cycloadducts tetrahydroxanthones 46 were 
obtained, while only exo cycloadducts 47 were observed with the (E)-diastereomers 12 (Scheme 
10). 
The reaction of N-phenylmaleimide with (Z)-3-styrylchromones 13 gave a mixture of the 
endo and exo cycloadducts 48 and 49, the endo cycloadducts being the most abundant ones 
(Scheme 11). The reaction of N-phenylmaleimide with (E)-3-styrylchromones 12 yielded only 
the exo cycloadducts 49. It was postulated that due to the lower reactivity of N-phenylmaleimide, 
compared with N-methylmaleimide, a part of (Z)-3-styrylchromones could isomerise into (E)-3-
styrylchromones under microwave irradiation which reacted with N-phenylmaleimide giving the 
exo cycloadducts 49.  
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3.2.Styrylchromones as dienophiles 
In the previous section the use of 2-styrylchromones as dienes in Diels-Alder reactions was 
reported; hereby their use as dienophiles will be reviewed. As far as we are aware only one paper 
was published on this subject.44 
2-Styrylchromones 37 reacted with ortho-benzoquinodimethane 51 (highly reactive diene 
generated in situ by thermal extrusion of SO2 from sulfone 50) to give chromones 52 (Scheme 
12). In some cases, when there was no substitution at C-α of 2-styrylchromones 37 (R = H), the 
obtained cycloadducts 52 could be dehydrogenated into 2-[2-(3-arylnaphthyl)]chromones 53, 
novel benzoflavone-type compounds. These oxidations were achieved by benzylic bromination 
with N-bromosuccinimide in the presence of benzoyl peroxide and followed by 
dehydrobromination of the products with triethylamine. To circumvent the bromination step, the 
ortho-benzoquinodibromomethane 54, generated in situ from α,α,α’,α’-tetrabromo-o-xylene, 
was used and the 2-[2-(3-arylnaphthyl)]chromones 53 were prepared in one-pot reaction. 
However, in the case of 4′-methoxy-2-styrylchromone (R = H and R′ = OCH3), chromone 53, 
was obtained in poor yield, due to the electron-donating substituent on the 2-styrylchromone B 
ring which decreases the reactivity of their Cα=Cβ double bond.  
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3.3.Transformation into pyrazolines 
2-Styrylchromones behave as dipolarophiles in the reaction with diazomethane, one of the most 
frequently used 1,3-dipoles in the preparation of pyrazolines. 2-Pyrazolines 56 were obtained as 
the main products in the reactions of 2-styrylchromones 37 with diazomethane, whereas the 
regioisomers 1-pyrazolines 57 were obtained as minor products (Scheme 13).29 Detailed studies 
performed ten years ago concluded that 1-pyrazolines similar to adduct 55 were formed as 
primary product and then rearranged to the more stable 2-pyrazoline isomers.45 In our case these 
isomerisations took place only in the case of compounds 55 because Hα is acidic whereas Hβ of 
their regioisomers 57 is not. 
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3.4.Transformation into 1,2,3-triazoles 
In the previous paragraph it was described the capacity of the Cα=Cβ double bond of  
2-styrylchromones to react with diazomethane in 1,3-dipolar cycloaddition reactions. In this 
section we will demonstrate the usefulness of the styryl double bond activated by the strongly 
electron-withdrawing chromonyl unit in the synthesis of 1,2,3-triazoles.46,47 The studies started 
with the bromination / dehydrobromination reactions of 2-styrylchromones in order to prepare 2-
(α-bromostyryl)-chromones 60 and/or 61 (Scheme 14). The results on the bromination studies 
indicated that using two molar equivalents of pyridinium tribromide only the brominated 
compounds 58 and 59 were obtained. 2-(1,2-Dibromo-2-phenylethyl)chromones 58 were 
dehydrobrominated by treatment with triethylamine and the isomeric (Z) and (E)-2-(α-
bromostyryl)chromones 60 and 61 were obtained. The desired 1,2,3-triazoles 62 were achieved 
by treating chromones 60 and 61 with an excess of sodium azide (Scheme 14, step A).46 
Further studies on the synthesis of these 1,2,3-triazoles 62 have shown that the bromination 
and dehydrobromination steps could be avoided since 4(5)-aryl-5(4)-(2-chromonyl)-1,2,3-
triazoles 62 can be directly prepared in a one-pot reaction from 2-(1,2-dibromo-2-
phenylethyl)chromones 58 (Scheme 14, step B) or even from 2-styrylchromones 37 (Scheme 14, 
step C).47 
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3.5.Transformation into pyrazoles 
It was recognized more than fifty years ago that chromones can react with hydrazine hydrate to 
give 5(3)-(2-hydroxyphenyl)pyrazoles. Thirty years later the structures of these reaction products 
were confirmed as pyrazoles and the reaction mechanism was explained.48 In 1997 we published 
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the first studies on the reactions of 2-styrylchromones with hydrazines which resulted in the 
formation of 3-(2-hydroxyphenyl)-5-styrylpyrazoles.49 Few years later, full detailed results on 
the reactions of 2-styrylchromones 63 with hydrazine hydrate26 and with methylhydrazine50 have 
been reported. 
In the reaction of 2-styrylchromones 63 with methylhydrazine, 3-(2-benzyloxy-6-hydroxy-
phenyl)-1-methyl-5-styrylpyrazoles 66 have been obtained as the only detectable products 
(Scheme 15). However, in the reactions of 2-styrylchromones 63 with hydrazine hydrate not only 
the expected 3-(2-benzyloxy-6-hydroxyphenyl)-5-styrylpyrazoles 65 but also 2-pyrazolines 67 
and pyrazoles 68 were obtained (Scheme 15). The formation of by-products 68 can be envisaged 
by reduction of the major reaction products 65 by diazene (N2H2), formed by oxidation of 
hydrazine. The study revealed that the quantities of the pyrazoles 68 increased with the 
increasing amount of hydrazine hydrate and/or with refluxing time longer than necessary for the 
disappearance of the starting chromone. The formation of 2-pyrazolines 67 can be explained on 
the basis of the reaction mechanism. First there is a nucleophilic attack at C-2 of 2-styryl-
chromones 63 and subsequent ring opening 64, followed by conjugate addition of hydrazine to 
the former C-β of the 2-styrylchromone. Obviously, the nucleophilic attack at the carbonyl group 
giving the major product 3-(2-benzyloxy-6-hydroxyphenyl)-5-styrylpyrazoles 65 is much more 
favorable. 
O
O
R'
R = H, Me, 
R' = H, Me, OMe, C(CH3)3
63
+
OBn
66
OBn
R
OH N NMe
R R'
OBn
65
OH N NH
R R'
+
OBn
68
OH N NH
R R'
OBn
67
OH
R R'
OH N NH
OBn
64
OH O HN
R R'
NH2
2
NH2NHMe
NH2NH2.H2O
 
Scheme 15 
 
The same reaction has been recently applied to 3-styrylchromones and it seems that these 
compounds are also good starting material in the synthesis of styrylpyrazoles. 4-Styryl-3-(2-
hydroxyphenyl)pyrazoles 48 have been synthesized from the reactions of 3-styrylchromones 
10,12 with hydrazine hydrate (Scheme 16).51 
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R = H, Me, 
R' = H, Me, OMe, C(CH3)3 69
OH N NH
O
O
R'
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R
R'
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Scheme 16 
 
3.6.Transformation into pyrimidines 
One of the last publications concerning the reactivity of styrylchromones deals with 
transformation of 3-styrylchromones into styrylpyrimidines16 as another example involving the 
ring opening of the chromone nucleus (Scheme 17). The reaction of 3-styrylchromones 70 with 
thiourea or guanidine afforded 2-thio-4-(2-hydroxyphenyl)-5-styrylpyrimidines 71 and 2-amino-
4-(2-hydroxyphenyl)-5-styrylpyrimidines 72, respectively. 
 
R = H, Me, OMe
71
OH
R
O
O
NO2
R
70
N N
SH
NO2
72
OH
R
N N
NH2
NO2
H2NCSNH2
H2NC(NH)NH2.HCl
 
Scheme 17 
 
 
Closing remarks 
 
Results compiled and discussed in this review unquestionably prove that styrylchromones 
became versatile and important oxygen heterocycles. Their proved biological activities and their 
utility in the synthesis of other heterocyclic compounds emphasize their importance. This paper 
highlights that work on their transformation has been done and several transformations can give 
rise to important targets. It is also evident that biological evaluations, especially in the case of 3-
styrylchromones should be further considered.  
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